Concentrum Wealth Management’s First Trust Bloomberg R&D Leaders ETF RND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$246K Sell
8,978
-7
-0.1% -$204 0.07% 95
2025
Q4
$273K Hold
8,985
0.08% 75
2025
Q3
$266K Hold
8,985
0.08% 70
2025
Q2
$241K Sell
8,985
-7,005
-44% -$169K 0.08% 69
2025
Q1
$361K Hold
15,990
0.13% 58
2024
Q4
$397K Sell
15,990
-1,750
-10% -$42.5K 0.14% 55
2024
Q3
$414K Buy
17,740
+3,255
+22% +$72.9K 0.16% 49
2024
Q2
$326K Buy
+14,485
New +$309K 0.14% 55

Other funds holding RND

Concentrum Wealth Management's RND Position: Q1 2026 in Review

Concentrum Wealth Management reduced its First Trust Bloomberg R&D Leaders ETF (RND) stake by 0.08% in Q1 2026, selling an estimated $204 and leaving 8,978 shares worth $246K. The position accounts for 0.07% of the portfolio, ranked #95.

Concentrum Wealth Management first reported a position in RND in Q2 2024 and has held it in 8 quarters since. The position peaked at $414K in Q3 2024. 3 funds tracked by Wall St. Rank hold RND as of Q1 2026.

  • Concentrum Wealth Management held 8,978 shares of First Trust Bloomberg R&D Leaders ETF worth $246K as of Q1 2026.
  • Concentrum Wealth Management sold 7 First Trust Bloomberg R&D Leaders ETF shares in Q1 2026, an estimated $204.
  • First Trust Bloomberg R&D Leaders ETF made up 0.07% of Concentrum Wealth Management's portfolio in Q1 2026, its #95 holding.
  • Concentrum Wealth Management first reported a position in First Trust Bloomberg R&D Leaders ETF in Q2 2024 and has held it in 8 quarters since.
  • Concentrum Wealth Management's First Trust Bloomberg R&D Leaders ETF position peaked at $414K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held First Trust Bloomberg R&D Leaders ETF as of Q1 2026.

Based on Concentrum Wealth Management's 13F filing for Q1 2026, filed 4 May 2026.